Prostate Power Play: Does Pik3ca Accelerate Pten-Deficient Cancer Progression?

TitleProstate Power Play: Does Pik3ca Accelerate Pten-Deficient Cancer Progression?
Publication TypeJournal Article
Year of Publication2018
AuthorsTriscott J, Rubin MA
JournalCancer Discov
Volume8
Issue6
Pagination682-685
Date Published2018 06
ISSN2159-8290
KeywordsAnimals, Class I Phosphatidylinositol 3-Kinases, Humans, Male, Mice, Orchiectomy, Phosphatidylinositol 3-Kinases, Prostatic Neoplasms, PTEN Phosphohydrolase
Abstract

PI3K pathway alterations are frequently recurrent in metastatic prostate cancer and are associated with the development of currently incurable castration-resistant disease. Candidate inhibitors that target single PI3K pathway members lack efficacy as demonstrated in multiple clinical trials. In this issue, Pearson and colleagues examine the functional importance of co-occurring PIK3CA and PTEN aberrations using a novel mouse model and demonstrate a synergistic acceleration of tumorigenesis that may be responsible for de novo metastatic prostate cancer. Cancer Discov; 8(6); 682-5. ©2018 AACRSee related article by Pearson et al., p. 764.

DOI10.1158/2159-8290.CD-18-0369
Alternate JournalCancer Discov
PubMed ID29858226
Grant ListP50 CA211024 / CA / NCI NIH HHS / United States